|
IL119685D0
|
|
4,5,6,7-tetrahydro-2-saccharinylmethyl aryl and aryloxy acetates
|
|
FI964173A0
|
|
Process for the preparation of therapeutically useful modified oligonucleotide compounds
|
|
FI960489A0
|
|
Methods for preparing saccharin derivatives and their intermediates useful as proteolytic enzyme inhibitors
|
|
EP0771207A1
|
|
Use of magnesium hydroxide as a stool softener
|
|
HU211641A9
|
|
3-arylcarbonyl-1-(c-attached-n-heteryl)-1h-indoles
|
|
HU211227A9
|
|
3-arylcarbonyl-1-(c-attached-n-heteryl)-1h-indoles
|
|
HU211706A9
|
|
Thioxanthenone antitumor agents
|
|
HU211613A9
|
|
Thioxanthenone antitumor agents
|
|
HU211286A9
|
|
Saccharin derivative proteolytic enzyme inhibitors
|
|
HU211665A9
|
|
Tetrazolyl-(phenoxy and phenoxyalkyl)-piperidinylpyridazines as antiviral agents
|
|
HU211967A9
|
|
3-arylcarbonyl-1h-indole-containing compounds
|
|
HU211699A9
|
|
(s)-(+)-hydroxychloroquine
|
|
US5622967A
|
|
Quinolone carboxamide Calpain inhibitors
|
|
US5614530A
|
|
Substituted N-arylmethyl and heterocyclmethyl-1H-pyrazolo[3,4-b]quinolin-4-amines and compositions and methods of use thereof
|
|
US5541168A
|
|
Substituted 2-(phosphinyloxymethyl)-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof
|
|
US5494925A
|
|
2-heterocyclyloxymethyl and 2-heterocyclylthiomethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof
|
|
US5512576A
|
|
2-substituted 1,2,5,-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof
|
|
US5430036A
|
|
6,11-substituted-6,11-dihydrobenzo[b]quinolizinium salts and compositions and method of use thereof
|
|
FI944968A0
|
|
Method for preparing saccharin derivatives
|
|
US5434159A
|
|
6,11-cyclyl-1,2,3,4,5,6,11,11a-octahydrobenzo[b]quinolines and compositions and method of use thereof
|
